Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer

被引：0
|
作者：
Mitsuro Kanda
Shuji Nomoto
Hisaharu Oya
Dai Shimizu
Hideki Takami
Soki Hibino
Ryoji Hashimoto
Daisuke Kobayashi
Chie Tanaka
Suguru Yamada
Tsutomu Fujii
Goro Nakayama
Hiroyuki Sugimoto
Masahiko Koike
Michitaka Fujiwara
Yasuhiro Kodera
机构：
[1] Nagoya University Graduate School of Medicine,Department of Gastroenterological Surgery (Surgery II)
来源：
Journal of Experimental & Clinical Cancer Research | / 33卷
关键词：
Gastric cancer; Dihydropyrimidinase-like 3; Expression; Prognosis; Biomarker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer
    Takashima, Yusuke
    Komatsu, Shuhei
    Ohashi, Takuma
    Kiuchi, Jun
    Kamiya, Hajime
    Shimizu, Hiroki
    Arita, Tomohiro
    Konishi, Hirotaka
    Shiozaki, Atsushi
    Kubota, Takeshi
    Okamoto, Kazuma
    Fujiwara, Hitoshi
    Tsuda, Hitoshi
    Otsuji, Eigo
    CANCER SCIENCE, 2022, 113 (06) : 1984 - 1998
  • [32] GGT5 facilitates migration and invasion through the induction of epithelial-mesenchymal transformation in gastric cancer
    Luo, Zhuang
    Chen, Yong
    Chen, Bangquan
    Zhao, Ziming
    Wu, Rongfan
    Ren, Jun
    BMC MEDICAL GENOMICS, 2024, 17 (01)
  • [33] Transketolase-Like Protein 1 and Glucose Transporter 1 in Gastric Cancer
    Ahopelto, Kaisa
    Laitinen, Alli
    Hagstrom, Jaana
    Bockelman, Camilla
    Haglund, Caj
    ONCOLOGY, 2020, 98 (09) : 643 - 652
  • [34] LAG3 in gastric cancer: it's complicated
    Ulase, Dita
    Behrens, Hans-Michael
    Krueger, Sandra
    Heckl, Steffen M.
    Ebert, Ulrike
    Becker, Thomas
    Roecken, Christoph
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10797 - 10811
  • [35] miRNA-633 and KAI1 as Potential Biomarkers of Malignant Melanoma with Gastric Cancer
    Wang, Zheng-Xiang
    Zhang, Guang-Jing
    Yang, Xiu-Fang
    Feng, Shi-Jun
    Ji, Shan-Shan
    Qi, Ya-Bin
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2023, 26 (05) : 1001 - 1014
  • [36] HHLA2 overexpression is a novel biomarker of malignant status and poor prognosis in gastric cancer
    Li Wei
    Liang Tang
    Haiyan Chang
    Song Huo
    Yan Li
    Human Cell, 2020, 33 : 116 - 122
  • [37] HHLA2 overexpression is a novel biomarker of malignant status and poor prognosis in gastric cancer
    Wei, Li
    Tang, Liang
    Chang, Haiyan
    Huo, Song
    Li, Yan
    HUMAN CELL, 2020, 33 (01) : 116 - 122
  • [38] Dysregulation of ECRG4 is associated with malignant properties and of prognostic importance in human gastric cancer
    You, Yanjie
    Hu, Shengjuan
    CANCER BIOMARKERS, 2022, 34 (01) : 55 - 66
  • [39] MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer
    An, Jia-Xiang
    Ma, Zhao-Sheng
    Ma, Ming-Hui
    Shao, Shuai
    Cao, Fei-Lin
    Dai, Dong-Qiu
    CANCER BIOMARKERS, 2019, 25 (02) : 127 - 132
  • [40] The Up-Regulated Expression of Mitochondrial Membrane Molecule RHOT1 in Gastric Cancer Predicts the Prognosis of Patients and Promotes the Malignant Biological Behavior of Cells
    Kong, Fanhao
    Yang, Siwen
    Shi, Ruimeng
    Peng, Yanyu
    MOLECULAR BIOTECHNOLOGY, 2025, 67 (03) : 1095 - 1108
12345